검색어 : 통합검색[Linney Laura]
총 12건 중 12건 출력
, 2/2 페이지
-
11
- Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
- Carzaniga, Laura; Linney, Ian D.; Rizzi, Andrea; Schmidt, Wolfgang; Knight, Christopher K.; Mileo, Valentina; Amadei, Francesco; Pastore, Fiorella; Miglietta, Daniela; Cesari, Nicola; Riccardi, Benedetta; Mazzucato, Roberta; Ghidini, Eleonora; Blackaby, Wesley P.; Patacchini, Riccardo; Battipaglia, Loredana; Villetti, Gino; Puccini, Paola; Catinella, Silvia; Civelli, Maurizio; Rancati, Fabio; Medicinal Chemistry Department , Charles River , Chesterford Research Park , Saffron Walden , CB10 1XL , Essex United Kingdom; Medicinal Chemistry and Drug Discovery Technologies Department , Chiesi Farmaceutici S.p.A., Research Center , Largo Belloli 11/a , 43122 Parma , Italy; Medicinal Chemistry Department , Charles River , Chesterford Research Park , Saffron Walden , CB10 1XL , Essex United Kingdom; Medicinal Chemistry Department , Charles River , Chesterford Research Park , Saffron Walden , CB10 1XL , Essex United Kingdom; Analytics and Early Formulations Department , Chiesi Farmaceutici S.p.A., Research Center , Largo Belloli 11/a , 43122 Parma , Italy; Analytics and Early Formulations Department , Chiesi Farmaceutici S.p.A., Research Center , Largo Belloli 11/a , 43122 Parma , Italy; Pharmacol; (Journal of medicinal chemistry, v.67, 2024, pp.9816-9841)
-
12
- Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
- Carzaniga, Laura; Linney, Ian D.; Rizzi, Andrea; Delcanale, Maurizio; Schmidt, Wolfgang; Knight, Christopher K.; Pastore, Fiorella; Miglietta, Daniela; Carnini, Chiara; Cesari, Nicola; Riccardi, Benedetta; Mileo, Valentina; Venturi, Luca; Moretti, Elisa; Blackaby, Wesley P.; Patacchini, Riccardo; Accetta, Alessandro; Biagetti, Matteo; Bassani, Franco; Tondelli, Marina; Murgo, Annalisa; Battipaglia, Loredana; Villetti, Gino; Puccini, Paola; Catinella, Silvia; Civelli, Maurizio; Rancati, Fabio; Medicinal Chemistry Department , Charles River, Chesterford Research Park , Saffron Walden, CB10 1XL Essex , United Kingdom; Chemistry Research and Drug Design Department , Chiesi Farmaceutici S.p.A, Research Center , Largo Belloli 11/a , 43122 Parma , Italy; Chemistry Research and Drug Design Department , Chiesi Farmaceutici S.p.A, Research Center , Largo Belloli 11/a , 43122 Parma , Italy; Medicinal Chemistry Department , Charles River, Chesterford Research Park , Saffron Walden, CB10 1XL Essex , United Kingdom; Medicinal Chemistry Department , Charles River, Chesterford Research Park , Saffron Walden, CB10 1XL Essex , United Kingdom; Pharmacology Department , Chiesi Farmaceutici S.p.A, Research Center , Largo Belloli 11/a , 43122 Parma , Italy; Pharmacology Department , Chiesi Farmaceutici S.p.A,; (Journal of medicinal chemistry, v.65, 2022, pp.10233-10250)
12
QUICK MENU
